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The combination of OCT4 expression and short-term exposure to reprogrammingmedia induces a state of transcriptional plasticity
in human fibroblasts, capable of responding to changes in the extracellular environment. Herewe provide characterization of iPSCs
established through continued culture of OCT4-induced plastic human fibroblasts in pluripotent-supportive reprogrammingmedia.
Human iPSCOCT4 are morphologically indistinguishable from conventionally derived iPSCs and express core proteins involved in
maintenance of pluripotency. iPSCOCT4 display bona fide functional pluripotency as measured by in vivo teratoma formation
consisting of the three germ layers.
© 2015 Elsevier B.V. This is an open access article under the CC BY-NC-ND license
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Figure 1 Generation of human induced pluripotent stem cells through continued exposure of OCT4-induced plastic human
fibroblasts to reprogramming media. (A) Cultured hFib iPSCOCT4 colonies. Red arrows indicate colony borders, scale bars represent
100 μm. (B) PCR showing exclusive genomic integration of OCT4 in iPSCOCT4. (C) RT-qPCR data examining total and exogenous OCT4
expression in FibOCT4, Fib, and TRA-1-60+iPSCOCT4 (P12-19). Bars represent mean + standard deviation, n = 3 technical replicates;
gene expression is normalized to GAPDH and relative to FibOCT4. (D) Comparison of RFLP signatures obtained for parent hFibs and
associated iPSCOCT4. (E) Representative flow cytometric analysis plots of pluripotent marker expression in iPSCOCT4. (F) Hematoxylin
and eosin staining of teratoma sections derived from iPSCOCT4 depicting cell derivatives of all three embryonic germ layers. Tissue
type is denoted, and associated area of interest is highlighted by either red circle or arrow. (G) Karyotype of iPSCOCT4 (P14-19) derived
from three independent hFib sources, generated by aCGH analysis, depicting the absence of copy number variation (Fib 2 iPSCOCT4) or
presence (Fib 1 and 3 iPSCOCT4) of genomic alterations in regions/chromosomes that are recurrently altered in cultured hPSCs.
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Reprogramming Factors: Exogenous OCT4 was expressed in
human fibroblasts through genomic integration of pSIN-EF1α-
OCT4-Puro lentivirus (Fig. 1B). OCT4 transgene expression in
derivative iPSCOCT4 lines provided minimal contribution to total
OCT4 expression (Fig. 1C) similar to that observed in iPSCOSNL
(Yu et al., 2007) and iPSCOSKM (Takahashi et al., 2007).
Cell line origin: Matching RFLP signatures with starting
fibroblast cells confirms the origins of iPSCOCT4 (Fig. 1D).
Pluripotent stem cell marker analysis: iPSCOCT4 express
pluripotent markers SSEA3, TRA-1-60, OCT4, NANOG and
SOX2 as measured by flow cytometry (Fig. 1E).
Pluripotent functionality: iPSCOCT4 are capable of three
germ layer differentiation capacity as assessed by in vivo
teratoma assay (Fig. 1F).Materials and methods
Methodology used for cell line generation: Human adult dermal
fibroblasts (104 adherent cells perwell of a 12-well plate seeded
on Matrigel the day before transduction) were incubated for
24 h with concentrated pSIN-EF1α-OCT4-Puro lentiviral vector
in 0.5 mL hFib medium in the presence of 8 μg/mL polybrene
(Sigma Aldrich). After 24 h of incubation, 2 mL of reprogramming
medium (RM) [DMEM/F12 (Gibco) with 20% Knockout Serum
Replacement (Gibco), 100 μM β-mercaptoethanol, 100 μM
nonessential amino acid (Gibco), 1 mM L-glutamine (Gibco)
supplemented with 16 ng/mL basic fibroblast growth factor
(bFGF) and 30 ng/mL insulin-like growth factor (IGFII)] were
added to the well. Following a further 24 h of incubation,
lentiviral transduction conditions were replaced entirely with
RM. Cells were maintained in this condition for prolonged
culturewithmedia changes and removal of areas of overgrown
fibroblasts as necessary. iPSC colonies emerged between days
45 and 93, and were mechanically isolated and further
expanded in mouse embryonic fibroblast conditioned media.Flow cytometry
Human Fib iPSCOCT4 were dissociated to single cell sus-
pensions using TrypLE Express and were analyzed for the
presence of SSEA3-PE and TRA-1-60-Alexa Fluor 647 (BD
Pharmingen) cell surface markers. For detection of intracel-
lular pluripotent transcription factors cells were fixed and
permeabilized using the BD Cytofix/Cytoperm kit. Cells were
incubated overnight at 4 °C with conjugated antibodies
OCT4-Alexa Fluor 488, SOX2-Alexa Fluor 647 and NANOG-PE
(BD Pharmingen). Flow cytometric analysis was performed using
the BD LSRII Flow Cytometer with BD FACSDiva software and
analyzed with FlowJo software (Tree Star Inc).Teratoma formation
To assess the development potential of hFib iPSCOCT4 in vivo,
cells were collected by collagenase IV treatment and injected
into the left testicle of NOD/SCID mice (approximately one
well of a 6 well plate of 80% confluence for each mouse). At
eight to ten weeks, teratomas were harvested, dissected and
fixed with 4% paraformaldehyde. Samples were embedded in
paraffin and processed with hematoxylin and eosin staining.
Verification and authentication
Karyotype: iPSCOCT4 lines derived from three independent
fibroblast sources were analyzed by array comparative
genomic hybridization (aCGH) to assess karyotype at a
genomic resolution greater than that obtained using standard
cytogenetic procedures. One iPSC line possessed normal
karyotype, while the others possessed two and five amplifica-
tions, the majority of which are found in regions/chromo-
somes that are recurrently altered in PSCs (Fig. 1G) (Baker et
al., 2007; Martins-Taylor et al., 2011; Taapken et al., 2011).
iPS line identity: Matching RFLP signatures with starting
fibroblast cells confirms the origins of iPSCOCT4 (Fig. 1D).
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